登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 3855 条符合本次的查询结果， 用时 2.1091746 秒

381. Brain Change in Addiction as Learning, Not Disease.

作者: Marc Lewis.
来源: N Engl J Med. 2018年379卷16期1551-1560页

382. Classification, Ontology, and Precision Medicine.

作者: Melissa A Haendel.;Christopher G Chute.;Peter N Robinson.
来源: N Engl J Med. 2018年379卷15期1452-1462页

383. Next-Generation Sequencing to Diagnose Suspected Genetic Disorders.

作者: David R Adams.;Christine M Eng.
来源: N Engl J Med. 2018年379卷14期1353-1362页

384. Acne Vulgaris.

作者: Andrea L Zaenglein.
来源: N Engl J Med. 2018年379卷14期1343-1352页

385. Alcohol Use in Patients with Chronic Liver Disease.

作者: Daniel Fuster.;Jeffrey H Samet.
来源: N Engl J Med. 2018年379卷13期1251-1261页

386. Antibody-Mediated Rejection of Solid-Organ Allografts.

作者: Alexandre Loupy.;Carmen Lefaucheur.
来源: N Engl J Med. 2018年379卷12期1150-1160页

387. Aspirin-Exacerbated Respiratory Disease.

作者: Andrew A White.;Donald D Stevenson.
来源: N Engl J Med. 2018年379卷11期1060-1070页

388. Primary Hyperparathyroidism.

作者: Karl L Insogna.
来源: N Engl J Med. 2018年379卷11期1050-1059页

389. Circulating Extracellular Vesicles in Human Disease.

作者: Ravi Shah.;Tushar Patel.;Jane E Freedman.
来源: N Engl J Med. 2018年379卷10期958-966页

390. Peripheral Nerve Blocks for Hand Procedures.

作者: Janak Chandrasoma.;T Kyle Harrison.;Howard Ching.;Lindsey Vokach-Brodsky.;Larry F Chu.
来源: N Engl J Med. 2018年379卷10期e15页

391. Langerhans-Cell Histiocytosis.

作者: Carl E Allen.;Miriam Merad.;Kenneth L McClain.
来源: N Engl J Med. 2018年379卷9期856-868页

392. Lynch Syndrome-Associated Colorectal Cancer.

作者: Frank A Sinicrope.
来源: N Engl J Med. 2018年379卷8期764-773页

393. Clinical Course and Management of Hypertrophic Cardiomyopathy.

作者: Barry J Maron.
来源: N Engl J Med. 2018年379卷7期655-668页

394. Acute Viral Encephalitis.

作者: Kenneth L Tyler.
来源: N Engl J Med. 2018年379卷6期557-566页

395. Sequencing of Circulating Cell-free DNA during Pregnancy.

作者: Diana W Bianchi.;Rossa W K Chiu.
来源: N Engl J Med. 2018年379卷5期464-473页
Sequence analysis of cell-free DNA (cfDNA) fragments that circulate in the blood of pregnant women, along with the translation of this method into screening for fetal chromosome abnormalities, is a success story of modern genomic medicine. In less than a decade, prenatal cfDNA testing has gone from small, proof-of-principle studies to a global transformation of prenatal care. As of late 2017, a total of 4 million to 6 million pregnant women had had DNA from their plasma analyzed to screen for fetal aneuploidy. The exponential growth of the test has been a function of the role of the biotechnology industry in its development and marketing. Here we review what has been learned from the wide-scale implementation of this testing, how it has changed prenatal clinical care, and what ethical concerns have arisen, and we speculate about what lies ahead.

396. Update on Keratinocyte Carcinomas.

作者: Kishwer S Nehal.;Christopher K Bichakjian.
来源: N Engl J Med. 2018年379卷4期363-374页

397. Psychotic Disorders.

作者: Jeffrey A Lieberman.;Michael B First.
来源: N Engl J Med. 2018年379卷3期270-280页

398. Chronic Limb-Threatening Ischemia.

作者: Alik Farber.
来源: N Engl J Med. 2018年379卷2期171-180页

399. Chimeric Antigen Receptor Therapy.

作者: Carl H June.;Michel Sadelain.
来源: N Engl J Med. 2018年379卷1期64-73页

400. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.

作者: Deborah Cook.;Gordon Guyatt.
来源: N Engl J Med. 2018年378卷26期2506-2516页
共有 3855 条符合本次的查询结果， 用时 2.1091746 秒